Increasing Prevalence of Chronic Diseases Acting as a Major Driver for the Advanced Drug Delivery Systems Market

Global Advanced Drug Delivery Systems Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Advanced Drug Delivery Systems Market During 2026–2030?

The advanced drug delivery systems market has experienced robust growth in recent years. Its value is projected to increase from $285.59 billion in 2025 to $310.15 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. The expansion observed in the past can be attributed to the broadening of pharmaceutical R&D activities, the increasing prevalence of chronic diseases, progress in formulation science, the rise of injectable drug therapies, and a heightened emphasis on treatment efficacy.

The advanced drug delivery systems market is anticipated to experience substantial growth in the coming years, with its size expected to reach $433.56 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period can be attributed to factors such as the escalating demand for personalized medicine, the increasing adoption of biologics, the proliferation of nanotechnology-based therapies, a heightened emphasis on minimizing drug side effects, and growing investments in advanced pharmaceutical delivery platforms. Major trends projected for this period include the increasing integration of targeted drug delivery technologies, a rising utilization of nanocarrier-based formulations, a growing need for controlled release systems, the broadened availability of biologic and biosimilar delivery solutions, and an enhanced focus on patient-centric drug administration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12683&type=smp

What Drivers Are Expected To Influence The Advanced Drug Delivery Systems Market During The Forecast Period?

The future expansion of the advanced drug delivery systems market is anticipated to be driven by the rising occurrence of chronic conditions. These conditions are defined as health issues persisting for a year or longer, often requiring ongoing medical attention, limiting daily activities, or both. They stem from various risk factors such as tobacco use, exposure to secondhand smoke, unhealthy diets, lack of physical activity, and excessive alcohol consumption. Advanced drug delivery systems play a crucial role by enabling the precise targeting of therapeutic agents to specific areas of the body impacted by chronic illnesses. This targeted approach ensures that medications reach their intended location, thereby enhancing their efficacy and reducing adverse effects. A notable example from May 2023, reported by The United Nations (UN), highlights that chronic diseases account for seven out of 10 deaths in the US, claiming over 1.7 million American lives annually. Consequently, the growing prevalence of chronic conditions is a significant factor boosting the advanced drug delivery systems market.

How Are The Various Segments Of The Advanced Drug Delivery Systems Market Categorized?

The advanced drug delivery systems market covered in this report is segmented –

1) By Type: Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types

2) By Carrier Type: Liposomes, Nanoparticles, Microspheres, Other Carrier Types

3) By Technology: Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies

4) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS (Central Nervous System), Ophthalmology, Inflammatory Diseases, Infections, Other Applications

5) By End User: Hospitals, Specialized clinics, Clinical Research And Development Centers

Subsegments:

1) By Oral Drug Delivery System: Solid Dosage Forms, Liquid Dosage Forms, Novel Oral Delivery Systems

2) By Injection-Based Drug Delivery System: Autoinjectors, Microneedle-Based Systems

3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers

4) By Transdermal Drug Delivery System: Transdermal Patches, Microneedle Patches, Iontophoresis Systems

5) By Transmucosal Drug Delivery System: Buccal Delivery Systems, Sublingual Delivery Systems, Nasal Delivery Systems

6) By Carrier-Based Drug Delivery System: Liposomes, Nanoparticles, Dendrimers, Niosomes

7) By Other Types: Implantable Drug Delivery Systems, Targeted Delivery Systems, Bioadhesive Drug Delivery Systems

What Trends Are Affecting The Expansion Of The Advanced Drug Delivery Systems Market?

Major companies operating in the advanced drug delivery system market are prioritizing the development of innovative solutions, such as subcutaneous biologic delivery technologies, to satisfy the growing demand for convenient, rapid, and patient-friendly administration of complex therapies. Subcutaneous biologic delivery facilitates the administration of high-volume drugs under the skin, offering a less invasive alternative to traditional intravenous infusion. For instance, in June 2023, Halozyme Therapeutics, Inc., a US-based biopharmaceutical company, revealed the FDA approval of VYVGART Hytrulo with ENHANZE, a novel subcutaneous formulation for generalized myasthenia gravis. This product combines efgartigimod alfa with Halozyme’s recombinant human hyaluronidase PH20 (rHuPH20), enabling swift, high-volume subcutaneous delivery through a single injection. It reduces infusion time to seconds, improves patient convenience, supports treatment outside hospital settings, and maintains clinical efficacy comparable to IV administration.

Which Major Firms Influence Developments In The Advanced Drug Delivery Systems Market?

Major companies operating in the advanced drug delivery systems market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation

Read the full advanced drug delivery systems market report here:

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Which Region Is Forecast To Lead The Advanced Drug Delivery Systems Market In Terms Of Market Size?

North America was the largest region in the advanced drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Advanced Drug Delivery Systems Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12683&type=smp

Browse Through More Reports Similar to the Global Advanced Drug Delivery Systems Market 2026, By The Business Research Company

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Smart Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model